Umeå life science company QureTech Bio has received a SEK 3 million grant from the Swelife innovation programme (funded by the Swedish Government via Vinnova) to make antibiotic-resistant bacteria sensitive to different antibiotics again.
“We are delighted to receive this grant, as it will enable us to create a product that can help patients and save lives,” says Fredrik Almqvist, CEO of QureTech Bio.
An all new call for “Collaboration projects for better health” will open in December 2018. The strategic innovation programmes Swelife and MedTech4Health join forces to support development and implementation of highly innovative solusions that can contribute to better health, prevention, diagnostics, monitoring and treatments of disease. The budget for 2018 is 130 M SEK and projects can apply for up to 3 million SEK per project.
The results from the evaluation of the highly competitive national call “Projects for Better Health” were announced on March 18th. Again, two UBI-related cases are among the 22 successful applicants who receive funding. The total sum granted is 20,5 million SEK.
A new national call named “Projekt för Bättre Hälsa” opens today and is a joint innovation drive from the strategic national research programmes SweLife and MedTech4Health. Collaboration is mandatory – but each applicant can land up to one million SEK in funding if successful. SweLife offers hands-on support to make that happen for your team.
The business coaches at Umeå Biotech Incubator have collected an impressive know-how over the years. With their inside position of some of the most innovative medical solusions they know how to get a life science company to thrive and grow.
